Company Filing History:
Years Active: 2019
Title: The Innovations of Inventor Eric Tagat
Introduction: Eric Tagat, an accomplished inventor based in Sucy en Brie, France, has made significant contributions to the field of biopharmaceuticals. His work focuses on developing mammalian cell lines that express functional nematode acetylcholine receptors, paving the way for groundbreaking advancements in high-throughput screening assays for pharmaceutical compounds.
Latest Patents: Eric Tagat holds a prominent patent titled "Mammalian cell lines expressing functional nematode acetylcholine receptors and use thereof for high-throughput screening assays." This innovative patent describes the creation of stable mammalian cell lines that successfully express functional ion channels, facilitated by the stable co-expression of the chaperone protein RIC3. These advancements play a crucial role in screening new parasiticidal and nematocidal compounds, making them invaluable for the pharmaceutical industry.
Career Highlights: Throughout his professional journey, Eric has worked with notable companies in the life sciences sector. He has gained experience at Boehringer Ingelheim Animal Health, Inc. and Sanofi, where he contributed to various pioneering projects. His expertise in pharmacology and supportive roles in product development have positioned him as a respected figure in his field.
Collaborations: Eric Tagat has collaborated with talented individuals such as Lance Hammerland and Brenda Bondesen, leveraging their collective expertise to advance scientific research. These collaborations have further enhanced his ability to drive forward innovative solutions in biopharmaceutical development.
Conclusion: Eric Tagat's dedication to innovation and his significant patent contributions highlight his role as a key inventor in modern biotechnology. His work not only furthers our understanding of nematode acetylcholine receptors but also opens new avenues for the discovery of effective parasiticidal compounds, positively impacting the agricultural and healthcare sectors.